Date Title Description PDF
26 Jul 2023 On buy-back programmes The Company reports the commencement, effective as of today, 26 July 2023, of a share buyback program.   Download
10 May 2023 On P&L The Company releases the press release related to the first quarter 2023 financial results Download
10 May 2023 On P&L The Company releases the first quarter 2023 financial results presentation Download
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The Company releases the full year 2022 financial results presentation. Download

Pages

Date Title Description PDF
04 Oct 2021 Liquidity and counterparty agreements Download
01 Sep 2021 On business and financial situation ROVI informs about the joint statement from Moderna and Takeda on the investigation of suspended lots of the vaccine Download
28 Jul 2021 On business and financial situation The company releases the press release related to first half 2021 financial results Download
28 Jul 2021 On business and financial situation ROVI releases the first half 2021 results presentation Download
05 Jul 2021 Liquidity contracts and specialists Liquidity contract: transactions conducted in the second quarter of 2021 Download

Pages

Date Title Description PDF
20 Feb 2018 Información sobre resultados ROVI releases the presentation related to the full year 2017 results Download
20 Feb 2018 Información sobre resultados ROVI releases the press release related to the full year 2017 results Download
20 Feb 2018 Informe anual de remuneraciones de los consejeros ROVI releases the 2017 annual report regarding remuneration of the members of the Board of Directors Download
20 Feb 2018 Informe Anual de Gobierno Corporativo ROVI releases the 2017 Annual Corporate Governance Report Download
20 Feb 2018 Otros sobre gobierno corporativo The Company informs about the agreements adopted by the Board of Directors Download

Pages